Currently, immunotherapy is the standard of care for patients with liver cancer. However, while newer immunotherapy medications, which use a person’s immune system to fight cancer, can slow the spread in many types of cancers, liver tumors often do not respond. University of Hawaiʻi Cancer Center researcher Benjamin Green, MD, led a team to conduct public impact research and published a study aimed to better understand why this happens.
Ola HAWAIʻI researchers are working to better understand the long-term impact of COVID, the role of exercise with type 2 diabetes and dietary impacts on the Native Hawaiian population.